Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 155

The DOI matches its Crossref record.

Induction of apoptosis by D-limonene is mediated by inactivation of Akt in LS174T human colon cancer cells

JIA, SHU-SHENG, XI, GUANG-PENG, ZHANG, MING, CHEN, YAN-BO, LEI, BO, DONG, XIN-SHU, YANG, YAN-MEI·2013·Oncology Reports
DOI 10.3892/or.2012.2093
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3892/or.2012.2093

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 38

  1. Sun, 2007, D-Limonene: safety and clinical applications, Altern Med Rev, 12, 259
  2. Hakim, 2000, Citrus peel use is associated with reduced risk of squamous cell carcinoma of the skin, Nutr Cancer, 37, 161, 10.1207/S15327914NC372_7 · DOI
  3. Maltzman, 1989, The prevention of nitrosomethylurea-induced mammary tumors by d-limonene and orange oil, Carcinogenesis, 10, 781, 10.1093/carcin/10.4.781 · DOI
  4. Elson, 1988, Anti-carcinogenic activity of d-limonene during the initiation and promotion/progression stages of DMBA-induced rat mammary carcinogenesis, Carcinogenesis, 9, 331, 10.1093/carcin/9.2.331 · DOI
  5. Uedo, 1999, Inhibition by D-limonene of gastric carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine in Wistar rats, Cancer Lett, 137, 131, 10.1016/S0304-3835(98)00340-1 · DOI
  6. Giri, 1999, d-limonene chemoprevention of hepatocarcinogenesis in AKR mice: Inhibition of c-jun and c-myc, Oncol Rep, 6, 1123
  7. Nakaizumi, 1997, d-Limonene inhibits N-nitrosobis(2-oxopropyl)amine induced hamster pancreatic carcinogenesis, Cancer Lett, 117, 99, 10.1016/S0304-3835(97)00207-3 · DOI
  8. Wattenberg, 1989, Inhibition of N-nitrosodiethylamine carcinogenesis in mice by naturally occurring organosulfur compounds and monoterpenes, Cancer Res, 49, 2689
  9. Vigushin, 1998, Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee, Cancer Chemother Pharmacol, 42, 111, 10.1007/s002800050793 · DOI · Paper page
  10. Steele, 1990, Inhibition of transformation in cultured rat tracheal epithelial cells by potential chemopreventive agents, Cancer Res, 50, 2068
  11. Maltzman, 1991, Effects of monoterpenoids on in vivo DMBA-DNA adduct formation and on phase I hepatic metabolizing enzymes, Carcinogenesis, 12, 2081, 10.1093/carcin/12.11.2081 · DOI
  12. Van der Logt, 2004, Effects of dietary anticarcinogens and nonsteroidal anti-inflammatory drugs on rat gastrointestinal UDP-glucuronosyltransferases, Anticancer Res, 24, 843
  13. Manuele, 2010, Limonene exerts antiproliferative effects and increases nitric oxide levels on a lymphoma cell line by dual mechanism of the ERK pathway: relationship with oxidative stress, Cancer Invest, 28, 135, 10.3109/07357900903179583 · DOI
  14. Lu, 2004, Inhibition of growth and metastasis of human gastric cancer implanted in nude mice by d-limonene, World J Gastroenterol, 10, 2140, 10.3748/wjg.v10.i14.2140 · DOI
  15. Hata, 2003, Induction of apoptosis by Citrus paradisi essential oil in human leukemic (HL-60) cells, In Vivo, 17, 553
  16. Ji, 2006, Induction of apoptosis by d-limonene is mediated by a caspase-dependent mitochondrial death pathway in human leukemia cells, Leuk Lymphoma, 47, 2617, 10.1080/00268970600909205 · DOI
  17. Franke, 2003, PI3K/Akt and apoptosis: size matters, Oncogene, 22, 8983, 10.1038/sj.onc.1207115 · DOI
  18. Bader, 2005, Oncogenic PI3K deregulates transcription and translation, Nat Rev Cancer, 5, 921, 10.1038/nrc1753 · DOI
  19. Niedermeier, 2009, Isoform-selective phosphoinositide 3′-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach, Blood, 113, 5549, 10.1182/blood-2008-06-165068 · DOI
  20. Cui, 2012, Studies on the expression patterns of class I PI3K catalytic subunits and its prognostic significance in colorectal cancer, Cell Biochem Biophys, 62, 47, 10.1007/s12013-011-9257-6 · DOI
  21. Page, 2000, Overexpression of Akt/AKT can modulate chemotherapy-induced apoptosis, Anticancer Res, 20, 407
  22. Opel, 2011, Targeting aberrant PI3K/Akt activation by PI103 restores sensitivity to TRAIL-induced apoptosis in neuroblastoma, Clin Cancer Res, 17, 3233, 10.1158/1078-0432.CCR-10-2530 · DOI
  23. Garcia-Echeverria, 2008, Drug discovery approaches targeting the PI3K/Akt pathway in cancer, Oncogene, 27, 5511, 10.1038/onc.2008.246 · DOI
  24. Crowder, 2000, Glycogen synthase kinase-3 beta activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal, J Biol Chem, 275, 34266, 10.1074/jbc.M006160200 · DOI
  25. Szanto, 2009, Critical role of bad phosphorylation by Akt in cytostatic resistance of human bladder cancer cells, Anticancer Res, 29, 159
  26. Cardone, 1998, Regulation of cell death protease caspase-9 by phosphorylation, Science, 282, 1318, 10.1126/science.282.5392.1318 · DOI · Paper page
  27. Kim, 2012, Geraniol induces cooperative interaction of apoptosis and autophagy to elicit cell death in PC-3 prostate cancer cells, Int J Oncol, 40, 1683
  28. Chaudhary, 2012, D-Limonene modulates inflammation, oxidative stress and Ras-ERK pathway to inhibit murine skin tumorigenesis, Hum Exp Toxicol, 31, 798, 10.1177/0960327111434948 · DOI
  29. Kaji, 2001, Inhibition by d-limonene of experimental hepatocarcinogenesis in Sprague-Dawley rats does not involve p21(ras) plasma membrane association, Int J Cancer, 93, 441, 10.1002/ijc.1353 · DOI
  30. Rabi, 2009, d-Limonene sensitizes docetaxel-induced cytotoxicity in human prostate cancer cells: Generation of reactive oxygen species and induction of apoptosis, J Carcinog, 8, 9, 10.4103/1477-3163.51368 · DOI
  31. Khan, 2008, Apoptosis by dietary agents for prevention and treatment of cancer, Biochem Pharmacol, 76, 1333, 10.1016/j.bcp.2008.07.015 · DOI
  32. Hsieh, 2010, Lunasin, a novel seed peptide, sensitizes human breast cancer MDA-MB-231 cells to aspirin-arrested cell cycle and induced apoptosis, Chem Biol Interact, 186, 127, 10.1016/j.cbi.2010.04.027 · DOI
  33. Sun, 2004, Apoptosis as a novel target for cancer chemoprevention, J Natl Cancer Inst, 96, 662, 10.1093/jnci/djh123 · DOI
  34. Baysan, 2007, Arsenic trioxide induces apoptosis via the mitochondrial pathway by upregulating the expression of Bax and Bim in human B cells, Int J Oncol, 30, 313
  35. Uren, 2007, Mitochondrial permeabilization relies on BH3 ligands engaging multiple prosurvival Bcl-2 relatives, not Bak, J Cell Biol, 177, 277, 10.1083/jcb.200606065 · DOI
  36. Chen, 2007, Caspase-9-induced mitochondrial disruption through cleavage of anti-apoptotic BCL-2 family members, J Biol Chem, 282, 33888, 10.1074/jbc.M702969200 · DOI
  37. Krystal, 2002, Inhibition of phosphatidylinositol 3-kinase-Akt signaling blocks growth, promotes apoptosis, and enhances sensitivity of small cell lung cancer cells to chemotherapy, Mol Cancer Ther, 1, 913
  38. Liu, 2006, Inhibition of the phosphatidylinositol 3-kinase/Akt pathway sensitizes MDA-MB468 human breast cancer cells to cerulenin-induced apoptosis, Mol Cancer Ther, 5, 494, 10.1158/1535-7163.MCT-05-0049 · DOI

Cited by

Metadata

Authors
JIA, S.-S., XI, G.-P., ZHANG, M., CHEN, Y.-B., LEI, B., DONG, X.-S., & YANG, Y.-M.
Venue
Oncology Reports
Publisher
Spandidos Publications
Published
2012-10-19
Volume
29
Issue
1
Pages
349-354
ISSN
  • 1021-335X
  • 1791-2431
DOI
10.3892/or.2012.2093
Cited by
155
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.